Skip to main content
Fig. 1 | Molecular Neurodegeneration

Fig. 1

From: Advances, challenges and future directions for stem cell therapy in amyotrophic lateral sclerosis

Fig. 1

Molecular mechanisms in the pathology of amyotrophic lateral sclerosis. a Schematic representation of healthy spinal cord motor neuron. b Schematic representation of ALS affected spinal cord motor neuron: 1) Astrocytes are not able to support neuronal functions and impaired glutamate clearance leads to neuronal excitotoxicity; 2) Defects in protein degradation pathways and disturbances in RNA processing result in protein aggregate formation, RNA toxicity and mitochondrial dysfunction; 3) The secretion of pro-inflammatory cytokines by predominant M1 activated microglia contributes to the development of an inflammatory milieu; 4) Failure of axonal architecture and transport functions, together with the alteration of the physiological role of oligodendrocytes results in 5) synaptic failure, denervation and finally, muscle atrophy

Back to article page